Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR

European Journal of Neuroscience

Volumn 18, Issue 9, 2003, Pages 2668-2672

  Hurley, Michael J ^a   Mash, Deborah C ^a   Jenner, Peter ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cerebellum; Dopamine receptors; Dopamine transporter; Parkinson's disease; RT PCR; Tyrosine hydroxylase

Indexed keywords

BIOCHEMICAL MARKER; BRAIN PROTEIN; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; LEVODOPA; MESSENGER RNA; TYROSINE 3 MONOOXYGENASE;

AGED; ARTICLE; AUTOPSY; BRAIN REGION; BRAIN TISSUE; CEREBELLUM; CONTROLLED STUDY; DISEASE MARKER; DOPAMINERGIC TRANSMISSION; DYING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SYMPTOM; TISSUE DISTRIBUTION;

AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; AUTOPSY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CEREBELLUM; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; LEVODOPA; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PARKINSON DISEASE; RECEPTORS, DOPAMINE; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE;

EID: 0344442712     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2003.02963.x     Document Type: Article

References (39)

1. Altschul, S.F., Gish, W., Miller, W., Myers, E.W. & Lipman, D.J. (1990) Basic local alignment search tool. J. Mol. Biol., 215, 403-410.
2. 3 receptors in the cerebellum. Brain Res., 737, 347-350.
3. Barili, P., Bronzetti, E., Ricci, A., Zaccheo, D. & Amenta, F. (2000) Microanatomical localization of dopamine receptor protein immunoreactivity in the cerebellar cortex. Brain Res., 854, 130-138.
4. Björklund, A. & Lindvall, O. (1984) Dopamine-containing systems in the CNS. In Björklund, A. & Hökfelt, T., (eds) Handbook of Chemical Neuroanatomy. Elsevier, Amsterdam, pp. 55-122.
5. 3 receptor mediated effect? Prog. Neuro-Psychopharmacol. Biol. Psychiat., 24, 39-49.
6. 2 receptor mRNA. Brain Res., 564, 203-219.
7. 2 subtypes of dopamine receptors in rat brain. J. Neurosci., 6, 3177-3188.
8. 2 receptors in brain of several mammalian species. J. Neural Trans., 80, 105-127.
9. Chen, J.Y.-R., Hsu, P.-C., Hsu, L.-L. & Yeh, G.-C. (2001) Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine (MPTP) in C57BL/6 mice. Neurosci. Lett., 314, 49-52.
10. Chrapusta, S.J., Egan, M.F., Masserano, J.M. & Wyatt, R.J. (1994) Dopamine release in the rat cerebellum and hippocampus: a tissue 3-methoxytyramine study. Brain Res., 655, 271-275.
11. Ciliax, B.J., Heilman, C., Demchyshyn, L.L., Pristupa, Z.B., Ince, E., Hersch, S.M., Niznik, H.B. & Levey, A.I. (1995) The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci., 15, 1714-1723.
12. 3 receptor mRNA. Neuropharmacol., 36, 1689-1696.
13. 3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur. J. Neurosci., 6, 1384-1387.
14. 3 receptor in the rat brain. Neurosci., 65, 731-745.
15. 2 receptors. Neurosci., 19, 125-137.
16. Feigin, A., Fukuda, M., Dhawan, V., Przedborski, S., Jackson-Lewis, V., Mentis, M.J., Moeller, J.R. & Eidelberg, D. (2001) Metabolic correlates of levodopa response in Parkinson's disease. Neurology, 57, 2083-2088.
17. 3H]-7-hydroxy-N,N-di-n- propyl-2-aminotetralin. Brain Res., 648, 222-228.
18. Hökfelt, T., Mårtensson, R., Björklund, A., Kleinau, S. & Goldstein, M. (1984) Distributional maps of tyrosine-hydroxylase- immunoreactive neurons in the rat brain. In Björklund, A. & Hökfelt, T., (eds), Handbook of Chemical Neuroantomy. Elsevier, Amsterdam, pp. 277-379.
19. Hornykiewicz, O. (1966) Dopamine (3-hydroxytyramine) and brain function. Pharmacol. Rev., 18, 925-964.
20. 1 receptor expression in human basal ganglia and Parkinson's disease. Brain Res. Mol. Brain Res., 87, 271-279.
21. Ikai, Y., Takada, M., Shinonaga, Y. & Mizuno, N. (1992) Dopaminergic and non-dopaminergic neurons in the ventral tegmental area of the rat project, respectively, to the cerebellar cortex and deep cerebellar nuclei. Neurosci., 51, 719-728.
22. Ito, M. (1984) The Cerebellum and Neural Control. Raven Press, New York.
23. 2-like receptors: An immunocytochemical study of subtype-specific antibodies in rat and human brain. J. Comp. Neurol, 402, 353-371.
24. 5 receptors of rat and human brain. Neurosci., 100, 689-699.
25. Kizer, J.S., Palkovits, M. & Brownstein, M.J. (1976) The projections of the A8, A9 and A10 dopaminergic cell bodes: Evidence for a nigral-hypothalamicmedian eminence dopaminergic pathway. Brain Res., 108, 363-370.
26. 3 receptor agonists. Polish J. Pharmacol., 53, 509-515.
27. 2 dopamine receptors. Neurosci., 73, 131-143.
28. Lloyd, K.G., Shibuya, M., Davidson, L. & Hornykiewicz, O. (1997) Chronic neuroleptic therapy: tolerance and GABA systems. In E.CostaE. & Gessa, G.L., (eds), Advances in Biochemical Psychopharmacology. Raven Press, New York, 16, pp. 409-415.
29. Melchitzky, D.S. & Lewis, D.A. (2000) Tyrosine hydroxylase-and dopamine transporter-immunoreactive axons in the primate cerebellum: Evidence for a lobular and laminar specific dopamine innervation. Neuropsychophamacol., 22, 466-472.
30. Middleton, F.A. & Strick, P.L. (1997) Cerebellar output channels. In Schmahmann, J.D., (ed.), The Cerebellum and Cognition. Academic press, San Diego, International Rev. Neurobiol., 41, pp. 61-82.
31. Panagopoulos, N.T., Papadopoulos, G.C. & Matsokis, N.A. (1991) Dopaminergic innervation and binding in the rat cerebellum. Neurosci. Lett., 130, 208-212.
32. Piao, Y.-S., Mori, F., Hayashi, S., Tanji, K., Yoshimoto, M., Kakita, A., Wakabayashi, W. & Takahashi, H. (2003) α-Synuclein pathology affecting Bergmann glia of the cerebellum in patients with α- synucleinopathies. Acta Neuropathol., 105, 403-409.
33. 3H]-flunitrazepam binding during continuous treatment of rats for up to 1 year with haloperidol, sulpiride or clozapine. J. Neural. Transm., 68, 113-125.
34. 3H]-leucine and horseradish peroxidase. Brain Res., 178, 17-40.
35. Stein, J.F. & Aziz, T.Z. (1999) Does imbalance between basal ganglia and cerebellar outputs cause movement disorders? Curr. Opin. Neurol., 12, 667-669.
36. Steward, O. & Banker, G.A. (1992) Getting the message from the gene to the synapse: sorting intracellular transport of RNA in neurons. Trends Neurosci., 15, 180-186.
37. Takada, M., Sugimoto, T. & Hattori, T. (1993) MPTP neurotoxicity to cerebellar Purkinje cells in mice. Neurosci. Lett., 150, 49-52.
38. Timmermann, L., Gross, J., Dirks, M., Volkmann, J., Freund, H.-J. & Schnitzler, A. (2003) The cerebral oscillatory network of parkinsonian resting tremor. Brain, 126, 199-212.
39. 125I]S (-) 5-OH-PIPAT. Brain Res., 778, 89-98.